Skip to main content

Table 5 Comparison of classification results between VIC and OncoKB on two case series

From: Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants

VIC

Melanoma in OncoKB

Total

Oncogenic

Likely oncogenic

Predicted oncogenic

Likely neutral

Unknown/NA

 Strong clinical significance

1

0

0

0

0

1 (0.35%)

 Potential clinical significance

5

3

0

0

4

12 (4.26%)

 Benign/likely benign

0

0

0

0

0

0 (0.00%)

 Uncertain significance

3

30

5

1

233

272 (95.44%)

 Total

9

33

5

1

237

285

VIC

NSCLC in OncoKB

Total

Oncogenic

Likely oncogenic

Predicted oncogenic

Likely neutral

Unknown/NA

 Strong clinical significance

2

0

0

0

0

2 (0.82%)

 Potential clinical significance

15

20

1

1

1

38 (15.57%)

 Benign/likely benign

0

0

0

0

0

0 (0.00%)

 Uncertain significance

5

39

7

1

152

204 (83.61%)

 Total

22

59

8

2

153

244